Tag Archives: anaesthesia
November 2018 Br J Cardiol 2018;25:131–132
Preventing potentially fatal anaesthetic accidents
BJC Staff
Dr Stella Chikumbanje uses the capnograph in a Malawi hospital Two of the most important incidents that capnography monitoring can detect – accidently placing a tracheal tube in the patient’s oesophagus and breathing circuit disconnections – can both lead to significant patient harm and mortality if not identified early and corrected quickly. A pilot site for the study was identified in Malawi. Anaesthesia providers received a one-day capnography training course and eight hospitals received a total of 40 capnographs donated by Medtronic. After six months of use, it was reported that a minimum of 57 lives had been saved. The team of anes
March 2016 Br J Cardiol 2016;23:10–11
In brief
BJCardio Staff
Approval for new heart failure treatment A breakthrough drug for the treatment of chronic heart failure is now available in the UK. The new drug sacubitril/valsartan (Entresto®, Novartis) has been approved for the treatment of adults with symptomatic heart failure with reduced left ventricular ejection fraction (HFREF). Sacubitril/valsartan – the first drug in the angiotensin receptor neprilysin inhibitor (ARNI) class of drugs – was found to be superior to an evidence-based dose of the angiotensin-converting enzyme (ACE) inhibitor, enalapril, in the PARADIGM-HF study, the largest heart failure study conducted to date. PARADIGM-HF (Pros
November 2004 Br J Cardiol 2004;11:468-73
Maximising the benefit from pre-operative cardiac evaluation for elective, non-cardiac surgery
Jonathan MT Pierce, Oliver Allenby-Smith, Jonathan Goddard
No content available
For healthcare professionals only
